These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 31072396)

  • 21. [BCG vaccines for the prevention of tuberculosis in the world].
    Hashimoto T
    Kekkaku; 1997 Nov; 72(11):629-37. PubMed ID: 9423301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCG coverage and the annual risk of tuberculosis infection over a 14-year period in the Philippines assessed from the Nationwide Prevalence Surveys.
    Tupasi TE; Radhakrishna S; Pascual ML; Quelapio MI; Villa ML; Co VM; Sarol J; Mangubat N; Reyes AC; Sarmiento A; Solon M; Solon F; Burton L; Lofranco VS; Rostrata MP; Mantala MJ
    Int J Tuberc Lung Dis; 2000 Mar; 4(3):216-22. PubMed ID: 10751066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effectiveness of BCG vaccination in preventing Mycobacterium tuberculosis infection and disease in Greenland.
    Michelsen SW; Soborg B; Koch A; Carstensen L; Hoff ST; Agger EM; Lillebaek T; Sorensen HC; Wohlfahrt J; Melbye M
    Thorax; 2014 Sep; 69(9):851-6. PubMed ID: 24969643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does effect of BCG vaccine decrease with time since vaccination and increase tuberculin skin test reaction?
    Subramani R; Datta M; Swaminathan S
    Indian J Tuberc; 2015 Oct; 62(4):226-9. PubMed ID: 26970464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of bacille Calmette-Guérin immunisation programs in Australia.
    Khandaker G; Beard FH; Dey A; Coulter C; Hendry AJ; Macartney KK
    Commun Dis Intell Q Rep; 2017 Mar; 41(1):E33-E48. PubMed ID: 28385137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.
    Mangtani P; Nguipdop-Djomo P; Keogh RH; Trinder L; Smith PG; Fine PE; Sterne J; Abubakar I; Vynnycky E; Watson J; Elliman D; Lipman M; Rodrigues LC
    Health Technol Assess; 2017 Jul; 21(39):1-54. PubMed ID: 28738015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic evaluation of universal BCG vaccination of Japanese infants.
    Rahman M; Sekimoto M; Takamatsu I; Hira K; Shimbo T; Toyoshima K; Fukui T
    Int J Epidemiol; 2001 Apr; 30(2):380-5. PubMed ID: 11369746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis.
    Martinez L; Cords O; Liu Q; Acuna-Villaorduna C; Bonnet M; Fox GJ; Carvalho ACC; Chan PC; Croda J; Hill PC; Lopez-Varela E; Donkor S; Fielding K; Graham SM; Espinal MA; Kampmann B; Reingold A; Huerga H; Villalba JA; Grandjean L; Sotgiu G; Egere U; Singh S; Zhu L; Lienhardt C; Denholm JT; Seddon JA; Whalen CC; García-Basteiro AL; Triasih R; Chen C; Singh J; Huang LM; Sharma S; Hannoun D; Del Corral H; Mandalakas AM; Malone LL; Ling DL; Kritski A; Stein CM; Vashishtha R; Boulahbal F; Fang CT; Boom WH; Netto EM; Lemos AC; Hesseling AC; Kay A; Jones-López EC; Horsburgh CR; Lange C; Andrews JR
    Lancet Glob Health; 2022 Sep; 10(9):e1307-e1316. PubMed ID: 35961354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia.
    Bennasrallah C; Kacem M; Dhouib W; Zemni I; Ben Fredj M; Abroug H; Djobbi A; Green A; Said SG; Maalel I; Stambouli S; Zhir W; Youssef HBH; Sriha Belguith A
    PLoS One; 2019; 14(8):e0219991. PubMed ID: 31381577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Long-term Effect of Bacille Calmette-Guérin Vaccination on Tuberculin Skin Testing: A 55-Year Follow-Up Study.
    Mancuso JD; Mody RM; Olsen CH; Harrison LH; Santosham M; Aronson NE
    Chest; 2017 Aug; 152(2):282-294. PubMed ID: 28087302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculin reactivity in a pediatric population with high BCG vaccination coverage.
    Lockman S; Tappero JW; Kenyon TA; Rumisha D; Huebner RE; Binkin NJ
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):23-30. PubMed ID: 10094166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current status of Bacille Calmette Guérin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines.
    Dierig A; Tebruegge M; Krivec U; Heininger U; Ritz N;
    Vaccine; 2015 Sep; 33(38):4994-9. PubMed ID: 26151543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberculosis vaccine: A journey from BCG to present.
    Fatima S; Kumari A; Das G; Dwivedi VP
    Life Sci; 2020 Jul; 252():117594. PubMed ID: 32305522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries.
    Brantsaeter AB; Romanus V; Andersen PH; Heldal E
    Int J Tuberc Lung Dis; 2009 Apr; 13(4):440-5. PubMed ID: 19335948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette-Guérin vaccination.
    Kobayashi S; Yoshiyama T; Uchimura K; Hamaguchi Y; Kato S
    Sci Rep; 2021 Aug; 11(1):15902. PubMed ID: 34354146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem.
    Styblo K; Meijer J
    Tubercle; 1976 Mar; 57(1):17-43. PubMed ID: 1085050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring spatial variation in BCG vaccination among children 0-35 months in Ethiopia: spatial analysis of Ethiopian Demographic and Health Survey 2016.
    Agegnehu CD; Alem AZ
    BMJ Open; 2021 Apr; 11(4):e043565. PubMed ID: 33910946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of Mycobacterium bovis transmission in a badger vaccine field trial.
    Aznar I; Frankena K; More SJ; O'Keeffe J; McGrath G; de Jong MCM
    Prev Vet Med; 2018 Jan; 149():29-37. PubMed ID: 29290298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
    Pereira SM; Barreto ML; Pilger D; Cruz AA; Sant'Anna C; Hijjar MA; Ichihara MY; Santos AC; Genser B; Rodrigues LC
    Lancet Infect Dis; 2012 Apr; 12(4):300-6. PubMed ID: 22071248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.